CGM (continuous blood glucose monitoring systems) provides information on a minute-by-minute basis.
Artificial intelligence algorithms analyze and visualize this data, providing a comprehensive view of a person's health status and making recommendations.
CGM, combined with artificial intelligence, is the future in recognizing and treating diseases that require blood glucose monitoring.
The CGM device has already become a part of many people's lives and is gaining ground.
Companies that sell these devices increase their capitalization on a monthly basis as the number of users is growing and shows no tendency to decrease.
MLC Engineering is in a highly profitable niche with little competition.
Join the project now and become a share owner in a promising company!
